NCT03292146 - Effects of Denosumab on Bone Mineral Density in Women With Anorexia Nervosa: A Pilot Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 25, 2017

Primary Completion Date

July 22, 2021

Study Completion Date

July 22, 2021

Conditions

Bone DensityBone LossAnorexia NervosaEating DisorderAtypical Anorexia Nervosa

Interventions

DRUG

Denosumab 60 MG [Prolia]

Denosumab 60mg injection at baseline and 6 months

DRUG

Placebo Injection

Placebo Injection at baseline and 6 months

DRUG

Alendronate 70Mg Tab

Alendronate 70mg PO weekly starting at Month 12 through 24 months.

Trial Locations (1)

Massachusetts General Hospital, Boston